Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 15 | $1,805,965 |
| Sells | 20 | $116,425 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 03 Jan 2025 17:05 | ATHA | Athira Pharma Inc | SAN MARTIN JAVIER | CHIEF MEDICAL OFFICER | 02 Jan 2025 | Sale | 10,826 | 0.5619 | 6,083 | D |
| 03 Jan 2025 17:04 | ATHA | Athira Pharma Inc | LITTON MARK JAMES | President and CEO | 02 Jan 2025 | Sale | 25,107 | 0.5619 | 14,108 | D |
| 03 Jan 2025 17:03 | ATHA | Athira Pharma Inc | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | 02 Jan 2025 | Sale | 8,510 | 0.5619 | 4,782 | D |
| 03 Jan 2025 17:01 | ATHA | Athira Pharma Inc | RENNINGER ROBERT | VP of Finance | 02 Jan 2025 | Sale | 2,881 | 0.5619 | 1,619 | D |
| 03 Jan 2025 17:00 | ATHA | Athira Pharma Inc | WORTHINGTON MARK | General Counsel and CCO | 02 Jan 2025 | Sale | 8,510 | 0.5619 | 4,782 | D |
| 05 Sep 2024 19:51 | ATHA | Athira Pharma Inc | GENGOS ANDREW | CFO and Chief Business Officer | 05 Sep 2024 | Sale | 1,272 | 0.566 | 720 | D |
| 05 Sep 2024 19:50 | ATHA | Athira Pharma Inc | LENINGTON RACHEL | COO and CDO | 05 Sep 2024 | Sale | 2,525 | 0.566 | 1,429 | D |
| 05 Sep 2024 19:49 | ATHA | Athira Pharma Inc | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | 05 Sep 2024 | Sale | 2,525 | 0.566 | 1,429 | D |
| 05 Sep 2024 19:48 | ATHA | Athira Pharma Inc | WORTHINGTON MARK | GENERAL COUNSEL | 05 Sep 2024 | Sale | 2,525 | 0.566 | 1,429 | D |
| 05 Sep 2024 19:47 | ATHA | Athira Pharma Inc | LITTON MARK JAMES | President and CEO | 05 Sep 2024 | Sale | 5,032 | 0.566 | 2,848 | D |
| 25 Jun 2024 19:21 | ATHA | Athira Pharma Inc | ROMANO KELLY A | Director | 21 Jun 2024 | Purchase | 15,000 | 2.2581 | 33,872 | D |
| 25 Jun 2024 19:21 | ATHA | Athira Pharma Inc | ROMANO KELLY A | Director | 24 Jun 2024 | Purchase | 27,400 | 2.4153 | 66,179 | D |
| 16 Feb 2024 16:40 | ATHA | Athira Pharma Inc | LENINGTON RACHEL | COO AND CDO | 05 Jan 2024 | Sale A | 2,412 | 2.91 | 7,019 | D |
| 16 Feb 2024 16:38 | ATHA | Athira Pharma Inc | LITTON MARK JAMES | CEO | 05 Jan 2024 | Sale A | 4,820 | 2.91 | 14,026 | D |
| 16 Feb 2024 16:37 | ATHA | Athira Pharma Inc | WORTHINGTON MARK | GENERAL COUNSEL | 05 Jan 2024 | Sale A | 2,412 | 2.91 | 7,019 | D |
| 16 Feb 2024 16:34 | ATHA | Athira Pharma Inc | GENGOS ANDREW | CFO AND CHIEF BUSINESS OFFICER | 05 Jan 2024 | Sale A | 1,208 | 2.91 | 3,515 | D |
| 16 Feb 2024 16:32 | ATHA | Athira Pharma Inc | CHURCH KEVIN | CHIEF SCIENTIFIC OFFICER | 05 Jan 2024 | Sale A | 2,412 | 2.91 | 7,019 | D |
| 08 Jan 2024 16:42 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 05 Jan 2023 | Sale | 1,208 | 2.91 | 3,515 | D |
| 08 Jan 2024 16:40 | ATHA | Athira Pharma Inc | LITTON MARK JAMES | Chief Executive Officer | 05 Jan 2024 | Sale | 4,820 | 2.91 | 14,026 | D |
| 08 Jan 2024 16:38 | ATHA | Athira Pharma Inc | WORTHINGTON MARK | General Counsel | 05 Jan 2024 | Sale | 2,412 | 2.91 | 7,019 | D |
| 08 Jan 2024 16:36 | ATHA | Athira Pharma Inc | CHURCH KEVIN | Chief Scientific Officer | 05 Jan 2023 | Sale | 2,412 | 2.91 | 7,019 | D |
| 08 Jan 2024 16:35 | ATHA | Athira Pharma Inc | LENINGTON RACHEL | Chief Operating Officer | 05 Jan 2024 | Sale | 2,412 | 2.91 | 7,019 | D |
| 29 Dec 2023 17:24 | ATHA | Athira Pharma Inc | PERCEPTIVE ADVISORS LLC | Director , 10% | 29 Dec 2023 | Purchase | 163,954 | 2.38 | 390,211 | I |
| 29 Dec 2023 17:24 | ATHA | Athira Pharma Inc | PERCEPTIVE ADVISORS LLC | Director , 10% | 28 Dec 2023 | Purchase | 409,598 | 2.44 | 999,419 | I |
| 29 Dec 2023 17:24 | ATHA | Athira Pharma Inc | PERCEPTIVE ADVISORS LLC | Director , 10% | 27 Dec 2023 | Purchase | 32,134 | 2.28 | 73,266 | I |
| 09 Jun 2023 17:06 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 07 Jun 2023 | Purchase | 11,719 | 3.4395 | 40,308 | D |
| 09 Jun 2023 17:06 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 07 Jun 2023 | Purchase | 2,859 | 3.4 | 9,721 | D |
| 09 Jun 2023 17:06 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 07 Jun 2023 | Purchase | 422 | 3.3576 | 1,417 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 05 Jun 2023 | Purchase | 10,000 | 3.0154 | 30,154 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 05 Jun 2023 | Purchase | 10,000 | 2.9999 | 29,999 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 05 Jun 2023 | Purchase | 10,000 | 2.9997 | 29,997 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 05 Jun 2023 | Purchase | 15,000 | 3 | 45,000 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 02 Jun 2023 | Purchase | 3,418 | 2.945 | 10,066 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 02 Jun 2023 | Purchase | 6,582 | 2.8598 | 18,823 | D |
| 06 Jun 2023 19:36 | ATHA | Athira Pharma Inc | GENGOS ANDREW | See Below | 02 Jun 2023 | Purchase | 10,012 | 2.75 | 27,533 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)